The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

Jasmohan S. Bajaj, K. Rajender Reddy, Puneeta Tandon, Florence Wong, Patrick S. Kamath, Guadalupe Garcia‐Tsao, Benedict Maliakkal, Scott W. Biggins, Paul J. Thuluvath, Michael B. Fallon, Ram M. Subramanian, Hugo Vargas, Leroy R. Thacker, Jacqueline G. O'Leary, North American Consortium for the Study of End‐Stage Liver Disease – 21 December 2015 – In smaller single‐center studies, patients with cirrhosis are at a high readmission risk, but a multicenter perspective study is lacking.

Aspartate β‐hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma

Yoshifumi Iwagami, Chiung‐Kuei Huang, Mark J. Olsen, John‐Michael Thomas, Grace Jang, Miran Kim, Qiushi Lin, Rolf I. Carlson, Carl E. Wagner, Xiaoqun Dong, Jack R. Wands – 19 December 2015 – Aspartate β‐hydroxylase (ASPH) is an enzyme overexpressed in human hepatocellular carcinoma (HCC) tumors that participates in the malignant transformation process. We determined if ASPH was a therapeutic target by exerting effects on cellular senescence to retard HCC progression.

Reconstruction of hepatic venous tributary in right liver living donor liver transplantation: The importance of the inferior right hepatic vein

Kyoji Ito, Nobuhisa Akamatsu, Keigo Tani, Daisuke Ito, Junichi Kaneko, Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo – 19 December 2015 – Special care must be taken in hepatic vein reconstruction to avoid outflow block in living donor liver transplantation (LDLT) with a right liver graft. We have used cryopreserved homologous veins to reconstruct the right hepatic vein (RHV), middle hepatic vein (MHV), MHV tributaries (V5 and V8), and inferior right hepatic vein (IRHV).

Subscribe to